ITMI20062100A1 - Metodo per la stimolazi0ne di cellule dendritiche e prodotto cellulare cosi'ottenuto per la immunoterapia autologa di tumori solidi umani - Google Patents

Metodo per la stimolazi0ne di cellule dendritiche e prodotto cellulare cosi'ottenuto per la immunoterapia autologa di tumori solidi umani

Info

Publication number
ITMI20062100A1
ITMI20062100A1 IT002100A ITMI20062100A ITMI20062100A1 IT MI20062100 A1 ITMI20062100 A1 IT MI20062100A1 IT 002100 A IT002100 A IT 002100A IT MI20062100 A ITMI20062100 A IT MI20062100A IT MI20062100 A1 ITMI20062100 A1 IT MI20062100A1
Authority
IT
Italy
Prior art keywords
stimulation
dendritic cells
solid tumors
cell product
human solid
Prior art date
Application number
IT002100A
Other languages
English (en)
Inventor
Gaetano Finocchiaro
Alfredo Martini
Serena Pellegatta
Original Assignee
Fondazione I R C C S Istituto Neurologico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fondazione I R C C S Istituto Neurologico filed Critical Fondazione I R C C S Istituto Neurologico
Priority to IT002100A priority Critical patent/ITMI20062100A1/it
Priority to EP07819442A priority patent/EP2083854A2/en
Priority to PCT/EP2007/009402 priority patent/WO2008052740A2/en
Priority to US12/447,853 priority patent/US8129183B2/en
Publication of ITMI20062100A1 publication Critical patent/ITMI20062100A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IT002100A 2006-10-31 2006-10-31 Metodo per la stimolazi0ne di cellule dendritiche e prodotto cellulare cosi'ottenuto per la immunoterapia autologa di tumori solidi umani ITMI20062100A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT002100A ITMI20062100A1 (it) 2006-10-31 2006-10-31 Metodo per la stimolazi0ne di cellule dendritiche e prodotto cellulare cosi'ottenuto per la immunoterapia autologa di tumori solidi umani
EP07819442A EP2083854A2 (en) 2006-10-31 2007-10-30 Method for stimulating dendritic cells and cell product thus obtained for the autologous immunotherapy of solid human tumours
PCT/EP2007/009402 WO2008052740A2 (en) 2006-10-31 2007-10-30 Method for stimulating dendritic cells and cell product thus obtained for the autologous immunotherapy of solid human tumours
US12/447,853 US8129183B2 (en) 2006-10-31 2007-10-30 Method for stimulating dendritic cells and cell product thus obtained for the autologous immunotherapy of solid human tumours

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002100A ITMI20062100A1 (it) 2006-10-31 2006-10-31 Metodo per la stimolazi0ne di cellule dendritiche e prodotto cellulare cosi'ottenuto per la immunoterapia autologa di tumori solidi umani

Publications (1)

Publication Number Publication Date
ITMI20062100A1 true ITMI20062100A1 (it) 2008-05-01

Family

ID=38983920

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002100A ITMI20062100A1 (it) 2006-10-31 2006-10-31 Metodo per la stimolazi0ne di cellule dendritiche e prodotto cellulare cosi'ottenuto per la immunoterapia autologa di tumori solidi umani

Country Status (4)

Country Link
US (1) US8129183B2 (it)
EP (1) EP2083854A2 (it)
IT (1) ITMI20062100A1 (it)
WO (1) WO2008052740A2 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008039874A2 (en) 2006-09-26 2008-04-03 Cedars-Sinai Medical Center Cancer stem cell antigen vaccines and methods
WO2008039974A2 (en) 2006-09-28 2008-04-03 Cedars-Sinai Medical Center Cancer vaccines and vaccination methods
PL2328923T3 (pl) 2008-09-02 2016-06-30 Cedars Sinai Medical Center Epitopy CD133
EP2427485B1 (en) 2009-05-07 2016-12-07 ImmunoCellular Therapeutics, Ltd. Cd133 epitopes
US20160022789A1 (en) * 2012-08-15 2016-01-28 Neostem Oncology, Llc Individualized high purity colon carcinoma stem cells, methods and use of the same
US20160058855A1 (en) * 2012-08-15 2016-03-03 Neostem Oncology, Llc High purity ovarian cancer stem cells for active autologous immune therapy
US10137182B2 (en) 2013-02-14 2018-11-27 Immunocellular Therapeutics, Ltd. Cancer vaccines and vaccination methods
US20160030535A1 (en) * 2013-03-11 2016-02-04 Neostem Oncology, Llc Method of Induction and Purification of a Cell Population Responsible for Vascular Mimicry and Use of Same
WO2014165103A1 (en) * 2013-03-12 2014-10-09 California Stem Cell, Inc. Individualized high-purity glioblastoma multiforme stem cells and methods for stimulating immune response
WO2016161309A1 (en) * 2015-04-01 2016-10-06 Colorado State University Research Foundation Optimized cancer stem cell vaccines
US11020465B2 (en) 2016-03-04 2021-06-01 The Trustees Of Columbia University In The City Of New York Development of dual whole cell-based vaccine against pancreatic cancer
WO2019152922A1 (en) * 2018-02-05 2019-08-08 Nant Holdings Ip, Llc Calreticulin and fusion proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984522B2 (en) * 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
WO2006113181A2 (en) 2005-04-08 2006-10-26 University Of Florida Research Foundation, Inc. Stem-like cells in bone sarcomas
WO2008039874A2 (en) * 2006-09-26 2008-04-03 Cedars-Sinai Medical Center Cancer stem cell antigen vaccines and methods

Also Published As

Publication number Publication date
EP2083854A2 (en) 2009-08-05
WO2008052740A2 (en) 2008-05-08
WO2008052740A3 (en) 2008-06-26
US20100071081A1 (en) 2010-03-18
US8129183B2 (en) 2012-03-06

Similar Documents

Publication Publication Date Title
ITMI20062100A1 (it) Metodo per la stimolazi0ne di cellule dendritiche e prodotto cellulare cosi'ottenuto per la immunoterapia autologa di tumori solidi umani
PL1814580T3 (pl) Metody stosowania il-21 do adoptywnej immunoterapii i identyfikacji antygenów guza
IL194438A (en) Diarrhylthiohydantoin Compounds, Pharmaceuticals Containing Them, Syntheses Methods and In Vitro Methods for Contacting them with Mammalian Cells
EP2155065A4 (en) PROCESS FOR THE IMAGE DISPLAY OF CELLS IN VIVO
FR2866655B1 (fr) Appareil et procede pour la preparation et la mise en culture de cellules
EP1827604A4 (en) METHOD AND COMPOSITIONS FOR ADOPTIVE IMMUNOTHERAPY
IL205393A0 (en) Antibodies that bind human dendritic and epithelial cell 205 (dec-205)
IL202154A0 (en) Novel amide derivative for inhibiting the growth of cancer cells
EP1962588A4 (en) METHOD AND COMPOSITION FOR GROWTH CONTROL AND DISEASE CONTROL
ZA201001903B (en) Use of human cells of myeloid leukaemia for expression of antibodies
PL2213725T5 (pl) Wolne od białek zwierzęcych pożywki do hodowli komórek
EP2142146A4 (en) INTERSPINED IMPLANTS AND PROCEDURE FOR THEIR IMPLANTATION
EP2224912A4 (en) IMPROVED COMPOSITIONS AND METHOD OF RELEASING NUCLEIC ACIDS
WO2007041190A3 (en) Polymer-based delivery system for immunotherapy of cancer
IL189079A (en) A method of packing medical products into cells
EP1685240A4 (en) IMPROVED METHODS FOR IN VITRO PROTEIN SYNTHESIS
IL184734A0 (en) Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
EP1636385A4 (en) INHIBITION OF GENE FUNCTION BY IN VIVO DISTRIBUTION OF GENE EXPRESSION INHIBITORS BASED ON POLYNUCLEOTIDES IN MAMMALIAN CELLS
EP3133074A3 (de) 7-azaindolderivate
EP1850665A4 (en) MEANS OF COMBATING APPLE WICKERS IN ORCHARD GARDENS
IL200764A0 (en) Composition comprising epha3 antibodies and use thereof for the treatment of solid tumors
GB2453661B (en) In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
EP2222839A4 (en) METHOD AND COMPOSITIONS FOR MODULATING THE DIFFERENTIATION OF PLURIPOTENTER CELLS
EP2199793A4 (en) METHOD FOR EVALUATING HUMAN DENDRITIC CELLS AND HUMAN-CELL IMMUNOTHERAPEUTICS
EP1636345A4 (en) METHOD FOR INDUCING THE DIFFERENTIATION OF MONOCYTES TO FUNCTIONAL DENDRITIC CELLS AND IMMUNO-THERAPEUTIC COMPOSITIONS CONTAINING SUCH DENDRITIC CELLS